[-] Show simple item record

dc.contributor.authorRoper, Jennifer T.eng
dc.contributor.authorRiley, Lyrad K.eng
dc.date.issued2013-10eng
dc.description.abstractHow should physicians interpret the new 2-hour oral glucose tolerance test in obstetric patients? Evidence-Based Answer: Screening at 24 to 28 weeks’ gestational age with a 2-hour oral glucose tolerance test (OGTT) is designed to identify patients with a 1.75 odds ratio of an adverse pregnancy related outcome compared with patients without gestational diabetes (GDM). While this test triples the number of patients identified as having GDM compared with screening with the 1-hour glucose tolerance test (SOR: B, case-control study and evidence-based guideline), it is not yet clear that this increased rate of diagnosis will improve maternal or fetal outcomes.eng
dc.identifier.citationEvidence-based practice 16, no. 10 (2013): E15-E16eng
dc.identifier.urihttp://hdl.handle.net/10355/41568eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionEvidence Based Practice, 2013eng
dc.relation.ispartofseriesEvidence-based practice 16, no. 10 (2013)eng
dc.relation.ispartofseriesHelpDesk answers (Evidence-based practice, 2013)eng
dc.subjectglucose tolerance, obstetric patients, pregnancy, gestational diabetes, GMDeng
dc.subject.FASTPregnancy -- Complications -- Diagnosiseng
dc.subject.FASTDiabetes in pregnancyeng
dc.subject.FASTGlucose tolerance testseng
dc.titleHow should physicians interpret the new 2-hour oral glucose tolerance test in obstetric patients?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record